Priority Date: 08.06.07 (EP 20070109880)

QUINOXALINE DERIVATIVES AS INHIBITORS OF THE TYROSINE KINASE ACTIVITY OF JANUS KINASES

  • Application ID: EP08760632
  • Status: No opposition filed within time limit

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Novartis Pharma AG is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 225 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 08.06.2007 - Priority Date (EP 20070109880)
  • 11.12.2008 - Publication A2 (WO2008148867)
  • 24.02.2010 - Publication A2 (EP2155201)
  • 01.08.2012 - Publication B1 (EP2155201)